Relaxin, Insulin, and Metabolic Syndrome: Untangling the Web of Metabolic Dissonance Metabolic syndrome, a constellation of interconnected risk factors including abdominal obesity, insulin resistance, dyslipidemia, and hypertension, poses a significant global health challenge. While insulin’s role in this condition is well-established, recent research has shed light on a surprising player: relaxin, a peptide hormone traditionally … Continue reading Relaxin and insulin with metabolic syndrome: